InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
T+90 hit rate
50%
T+90 mean return
-4.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by EMALFARB MARK A, Chairman & CEO. Insider active across 1 company, notably Dyadic International INC. Cumulatively, 9 filings have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €956k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 2 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
73,111 shares0Common StockSEC:0001437749-25-000545:0
124,454 shares0Common StockSEC:0001437749-24-012123:0
138,478 shares@ US$1.3815.8% of flowCommon StockSEC:0001437749-23-000582:0
26,486 shares@ US$4.339.0% of flowCommon StockSEC:0001437749-21-029224
26,486 shares@ US$4.330.30% mcap10.6% of flowCommon StockSEC:0001437749-21-029224:0
44,000 shares@ US$3.950.42% mcap14.9% of flowCommon StockSEC:0001437749-21-014443:0
44,000 shares@ US$3.9512.6% of flowCommon StockSEC:0001437749-21-014443
76,349 shares@ US$3.740.69% mcap24.5% of flowCommon StockSEC:0001437749-21-014193:0
76,349 shares@ US$3.7420.6% of flowCommon StockSEC:0001437749-21-014193
9 of 9 declarations
About EMALFARB MARK A
Mark A. Emalfarb is the President and CEO of Dyadic International Inc. He leads the company in the development of innovative biopharmaceutical solutions. His role involves guiding the overall strategy of Dyadic, with a focus on innovation and research. Mark is responsible for managing operations and driving the company's growth in the biopharmaceutical market.
